Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis

NCT05031104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-10-07

No results posted yet for this study

Summary

This study endeavored to evaluate the auxiliary effect of low-energy laser therapy (LLT) on pain, muscle performance, fatigue, and functional ability in children with juvenile idiopathic arthritis (JIA). Sixty patients with JIA were randomly allocated to the LLT group (n = 30, received LLT in addition to the standard exercise program) or the control group (n = 30, received standard exercise program only). Both groups were assessed for pain intensity, muscle performance, fatigue perception, and functional status.

Conditions

  • Juvenile Idiopathic Arthritis
  • Rheumatic Diseases
  • Chronic Knee Pain
  • Fatigue
  • Muscle Weakness
  • Polyarticular JCA

Interventions

OTHER

Physical Exercise

The control group received a standard exercise program for 40 minutes, three times a week for three successive months. The program encompassed aerobic, weight-bearing, proprioceptive, flexibility, and strengthening exercises.

OTHER

Physical Exercise plus Low-energy Laser Therapy

The LLT group received the same program in addition to the application of LLT on both knees, each session before exercises.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ragab K Elnaggar, PhD · Cairo University / Prince Sattam Bin Abdulaziz University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-21
Primary Completion
2020-01-02
Completion
2020-01-02

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031104 on ClinicalTrials.gov